Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/56/f2/b8/56f2b88c-f71b-11ca-2fa0-ecddc1044fe8/mza_2145894122309428224.jpg/600x600bb.jpg
MediCom Oncology Clinical Pearls Podcasts
MediCom Oncology
53 episodes
1 month ago
Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.
Show more...
Science
RSS
All content for MediCom Oncology Clinical Pearls Podcasts is the property of MediCom Oncology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.
Show more...
Science
https://i1.sndcdn.com/artworks-000320156169-nqc64f-t3000x3000.jpg
53-year-old woman presenting with severe fatigue and bruising
MediCom Oncology Clinical Pearls Podcasts
3 minutes 58 seconds
7 years ago
53-year-old woman presenting with severe fatigue and bruising
Hematopathologist Dr. Khoury presents a case snapshot showing the complexities of diagnosing AML, describing the importance of morphology, flow cytometry, cytogenetics, and molecular diagnostics.
MediCom Oncology Clinical Pearls Podcasts
Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.